Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02355613 : Comparative Evaluation of Two Different Radiosurgery
PhasePhase 3
AgesMin: 18 Years Max: 85 Years
Eligibility
Inclusion Criteria:

- Age 18 - 85 years

- 1 - 4 brain metastases

- Karnofsky performance status (KPS) ?70

- RPA 1 or 2

- Histopathologically confirmation of primary solid tumor

- Estimated survival ? 3 months as GPA score

- Written informed consent

Exclusion Criteria:

- Prior WBRT

- Age > 85 years

- KPS < 70

- RPA 3

- Diagnosis of small cell lung cancer (SCLC) or Lymphoproliferative disease

- Use of Avastin for at least 2 months after radiosurgery

- Pregnant women
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02355613      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740